Prospective Multicenter Study of Genetic Factors Predictive of the Pharmacodynamics of Trastuzumab in Patients With Metastatic Breast Cancer
OBJECTIVES:
Primary
- To evaluate the predictive value of genetic factors on the toxicity and efficacy of a
trastuzumab-based therapy in women with metastatic breast cancer.
Secondary
- To analyze tumor factors potentially related to the efficacy of trastuzumab (i.e.,
expression of proteins involved in cell proliferation and survival).
OUTLINE: This is a multicenter study.
Patients receive standard treatment with trastuzumab. Blood is collected periodically for
pharmacogenetic analysis.
Interventional
Primary Purpose: Treatment
Toxicity, including cardiotoxicity and immuno-allergic reactions
Yes
Jean Marc Ferrero, MD
Centre Antoine Lacassagne
Unspecified
CDR0000626782
NCT00896376
December 2005
Name | Location |
---|